Lataa...
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...
Tallennettuna:
Päätekijät: | , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
Elsevier
2022-06-01
|
Sarja: | American Journal of Ophthalmology Case Reports |
Aiheet: | |
Linkit: | http://www.sciencedirect.com/science/article/pii/S2451993622002055 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|